Ontology | Accession | Term | GO Evidence | Evidence Ontology (ECO) Code | Reference | Comments |
---|---|---|---|---|---|---|
Biological Process | GO:0051607 | defense response to virus |
Inferred from Sequence Model
Term mapped from: InterPro:TIGR01876
|
ECO:0000259 match to InterPro signature evidence used in automatic assertion |
||
Biological Process | GO:0043571 | maintenance of CRISPR repeat elements |
Inferred from Sequence Model
Term mapped from: InterPro:PF09704
|
ECO:0000259 match to InterPro signature evidence used in automatic assertion |
||
Molecular Function | GO:0004519 | endonuclease activity |
Inferred from Sequence Model
Term mapped from: InterPro:TIGR01876
|
ECO:0000259 match to InterPro signature evidence used in automatic assertion |
|
Analysis | Accession | Description | Interpro Accession | Interpro Description | Amino Acid Start | Amino Acid Stop | E-value |
---|---|---|---|---|---|---|---|
Gene3D | G3DSA:3.30.70.2660 | - | - | - | 1 | 220 | 4.6E-103 |
NCBIfam | TIGR02593 | JCVI: CRISPR-associated protein Cas5 | IPR013422 | CRISPR-associated protein Cas5, N-terminal | 5 | 46 | 6.3E-16 |
CDD | cd09752 | Cas5_I-C | - | - | 5 | 215 | 1.08209E-123 |
NCBIfam | TIGR01876 | JCVI: type I-C CRISPR-associated protein Cas5c | IPR010155 | CRISPR pre-crRNA endoribonuclease Cas5d | 7 | 215 | 2.1E-54 |
PIRSF | PIRSF029950 | UCP029950 | IPR010155 | CRISPR pre-crRNA endoribonuclease Cas5d | 1 | 223 | 3.4E-92 |
Pfam | PF09704 | CRISPR-associated protein (Cas_Cas5) | IPR021124 | CRISPR-associated protein, Cas5 | 5 | 215 | 7.0E-45 |